Cambridge Healthtech Institute’s Drug Discovery Chemistry is part of the World Preclinical Congress Europe to be held at the Sheraton Lisboa. This event will bring together drug discovery scientists from pharma/biotech companies and academia to talk about new technologies, open innovation, collaboration, and insightful case studies. Topics covered include: hit-to-lead identification and validation; lead optimization; designing safer drugs; working with new targets and drug modalities; evaluating new technologies for drug synthesis and screening; and will include a talk by Selcia’s Director of Drug Discovery entitled “Discovery of Potent Cyclophilin Inhibitors Based on Structural Simplification of Sanglifehrin A”.

More details can be found on the conference website